A 277

  • New Jersey Assembly Bill
  • 2020-2021 Regular Session
  • Introduced in Assembly Jan 14, 2020
  • Passed Assembly Jul 30, 2020
  • Passed Senate Jun 03, 2021
  • Signed by Governor Nov 08, 2021

Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*

Votes


Actions


Nov 08, 2021

Governor of New Jersey

Approved P.L.2021, c.285.

Jun 03, 2021

Senate

Substituted for S2035 (1R)

Senate

Passed Senate (Passed Both Houses) (38-0)

Feb 09, 2021

Senate

Reported out of Senate Committee, 2nd Reading

Aug 03, 2020

Senate

Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Jul 30, 2020

Assembly

Passed Assembly (74-0-0)

Mar 05, 2020

Assembly

Reported out of Assembly Committee with Amendments, 2nd Reading

Jan 14, 2020

Assembly

Introduced in the Assembly, Referred to Assembly Health Committee

Bill Text

Bill Text Versions Format
Introduced Version HTML
Reprint HTML

Related Documents

Document Format
Advance Law
Statement SHH 2/9/21 1R
Statement AHE 3/5/20

Sources

Data on Open States is updated periodically throughout the day from the official website of the New Jersey Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.